Sklar®

FDA UDI

Class I (US FDA UDI)

by Sklar Corporation

Identity

Trade Name: Sklar® FDA UDI
Generic Name: Orthopaedic osteotome blade, reusable FDA UDI
Device Name: OSTEOTOME CONVEX BAYONET 4.2MM FDA UDI
Model / Reference: 49-3440 FDA UDI
Description: OSTEOTOME CONVEX BAYONET 4.2MM FDA UDI

Identifiers

Primary DI / UDI-DI: 10649111206450 FDA UDI
FDA Product Code: EMM FDA UDI
GMDN Term: Orthopaedic osteotome blade, reusable FDA UDI

Classification

Device Class: Class I FDA UDI
Regulation Number: 872.4565 FDA UDI
Commercial Distribution: In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

FDA UDI

Single Use

FDA UDI

Implantable

FDA UDI

Contains Latex

FDA UDI

Prescription Use

FDA UDI

Over-the-Counter

FDA UDI

Convenience Kit

FDA UDI

Combination Product

FDA UDI

HCT/P

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

FDA UDI

Manufacturing Date

FDA UDI

Sterilization Method

Moist Heat or Steam Sterilization FDA UDI

Category: Orthopaedic osteotome blade, reusable

Sklar® by Sklar Corporation — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Orthopaedic osteotome blade, reusable.

SHORT ACETABULAR BLADE D44 mm LONG — HPF SRL · Class I
Shukla Knee S9KNEE — Shukla Medical · Class I
Discovery™ — Biomet Orthopedics, Inc. · Class I
RP Medical — Rp Medical, Inc. · Class I
Identity™ — Zimmer, Inc. · Class I
Arthrex® — Arthrex, Inc. · Class I
TC-100 — Smith & Nephew, Inc. · Class II
DISCOVERY 2.4MM X-LOCK — Biomet Orthopedics, Inc. · Class I

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Source	Region	Type	Cert / Approval No.	Class	Status
FDA UDI	United States	FDA UDI	Registered in GUDID	Class I	Pending data

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer: Sklar Corporation

Sources (1)

FDA UDI bc5e394c-1c30-4ee1-8b1e-1e29469e69fa 33 fields · synced May 30, 2026